Abivax S.A. (ABVX) stock

ABVXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as AAVXF

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 23, 2026Score 1/30

$90.20−1.24 (-1.36%)

Close on Nov 12, 2026Market cap $7.08BP/E –Yield –

Abivax gross margin

Gross margin is gross profit as a percentage of revenue.

Abivax has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?